Cohu's second quarter 2025 results were in line with guidance, showing increased test cell utilization across all segments and securing a significant design-win order. The company reported a GAAP net loss but achieved non-GAAP net income, indicating underlying operational improvements despite a challenging market.
Net sales for the second quarter of 2025 were $107.7 million, with approximately 63% recurring revenue.
GAAP net loss for the quarter was $16.9 million, or $0.36 per share.
Non-GAAP net income for the quarter was $0.7 million, or $0.02 per share.
Cash and investments increased by $8.6 million to $209.4 million at the end of the second quarter.
Cohu expects third quarter 2025 sales to be in a range of $125 million +/- $7 million, indicating anticipated growth.
Analyze how earnings announcements historically affect stock price performance